Healthcare
Novavax, Inc.
NVAX$10.12+8.00%
Price is delayed.
Add to Watchlist
About Novavax, Inc.
Novavax is a biotechnology company that develops and sells vaccines to prevent infectious diseases. The company makes Nuvaxovid, a COVID-19 vaccine, and has developed a malaria vaccine called R21. Novavax partners with large pharmaceutical companies like Sanofi and Pfizer to manufacture and distribute these vaccines around the world.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore